BDX

Dollar change +1.73
Percentage change 0.90	%

Peers: JNJ ABT DHR BAX TMO ISRG HOLX BSX ALGN XRAY

| Held by: VTI VOO IVV SPY VO VTV XLV VIG SDY IHI

Index	S&P 500	P/E	34.70	EPS (ttm)	5.56	Insider Own	0.18%	Shs Outstand	286.63M	Perf Week	-3.35%
Market Cap	55.31B	Forward P/E	12.99	EPS next Y	14.86	Insider Trans	-0.17%	Shs Float	286.10M	Perf Month	8.26%
Enterprise Value	73.84B	PEG	5.47	EPS next Q	3.92	Inst Own	91.95%	Short Float	1.81%	Perf Quarter	11.81%
Income	1.61B	P/S	2.59	EPS this Y	9.44%	Inst Trans	-0.47%	Short Ratio	1.86	Perf Half Y	-14.43%
Sales	21.39B	P/B	2.17	EPS next Y	3.32%	ROA	2.91%	Short Interest	5.18M	Perf YTD	-14.94%
Book/sh	88.87	P/C	67.54	EPS next 5Y	6.34%	ROE	6.26%	52W High	251.99 -23.42%	Perf Year	-18.91%
Cash/sh	2.86	P/FCF	21.69	EPS past 3/5Y	-5.10% 8.27%	ROIC	3.73%	52W Low	163.33 18.15%	Perf 3Y	-25.30%
Dividend Est.	4.04 (2.09%)	EV/EBITDA	13.93	Sales past 3/5Y	1.79% 4.47%	Gross Margin	45.08%	Volatility	1.64% 1.82%	Perf 5Y	-22.36%
Dividend TTM	4.07 (2.11%)	EV/Sales	3.45	EPS Y/Y TTM	14.24%	Oper. Margin	14.14%	ATR (14)	3.64	Perf 10Y	39.47%
Dividend Ex-Date	Sep 08, 2025	Quick Ratio	0.62	Sales Y/Y TTM	7.86%	Profit Margin	7.51%	RSI (14)	54.39	Recom	2.43
Dividend Gr. 3/5Y	4.60% 4.29%	Current Ratio	1.10	EPS Q/Q	19.11%	SMA20	0.49%	Beta	0.28	Target Price	203.12
Payout	64.86%	Debt/Eq	0.76	Sales Q/Q	10.40%	SMA50	5.51%	Rel Volume	0.48	Prev Close	191.25
Employees	74000	LT Debt/Eq	0.69	Earnings	Aug 07 BMO	SMA200	-6.13%	Avg Volume	2.78M	Price	192.98
IPO	Sep 25, 1963	Option/Short	Yes / Yes	EPS/Sales Surpr.	8.20% 0.41%	Trades		Volume	1,329,449	Change	0.90%

Date	Action	Analyst	Rating Change	Price Target Change
May-22-25	Downgrade	Citigroup	Buy → Neutral	$185
May-02-25	Downgrade	Raymond James	Outperform → Mkt Perform
May-02-25	Downgrade	Piper Sandler	Overweight → Neutral	$185
May-02-25	Downgrade	Goldman	Buy → Neutral	$192
May-01-25	Downgrade	William Blair	Outperform → Mkt Perform
May-01-25	Downgrade	Wells Fargo	Overweight → Equal Weight
May-01-25	Downgrade	BofA Securities	Buy → Neutral	$190
Oct-01-24	Upgrade	Citigroup	Neutral → Buy	$255 → $275
May-30-24	Initiated	Goldman	Buy	$274
Jul-24-23	Upgrade	Raymond James	Mkt Perform → Outperform	$305
May-30-23	Resumed	Morgan Stanley	Overweight	$295
May-05-23	Upgrade	Piper Sandler	Neutral → Overweight	$260 → $290
Apr-12-23	Upgrade	KeyBanc Capital Markets	Sector Weight → Overweight	$304
Jan-03-23	Upgrade	BofA Securities	Neutral → Buy	$250 → $290
Dec-12-22	Upgrade	Citigroup	Sell → Neutral	$221 → $250
Jul-11-22	Downgrade	Citigroup	Neutral → Sell	$265 → $235
Jun-24-22	Upgrade	Wells Fargo	Equal Weight → Overweight	$275
Mar-18-22	Resumed	Raymond James	Mkt Perform
Mar-02-22	Resumed	BofA Securities	Neutral	$290
Dec-08-21	Downgrade	Piper Sandler	Overweight → Neutral	$285 → $260

Show Previous Ratings

Aug-29-25 08:58AM	Becton, Dickinson and Company Generated Lower-Than-Expected Revenue in Q2 (Insider Monkey)
Aug-28-25 12:06PM	Are Options Traders Betting on a Big Move in Becton Dickinson Stock? (Zacks)
09:45AM	Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
Aug-27-25 09:40AM	Here's Why Becton Dickinson (BDX) is a Strong Value Stock (Zacks)
06:46AM	Tesla Stock 'Could Fall 90% Tomorrow,' Fund Manager Still Won't Buy Here's Where He's Investing Instead (Benzinga)
07:24PM	Loading…
Aug-19-25 07:24PM	Analyst Report: Becton, Dickinson and Company (Morningstar Research)
Aug-18-25 12:18PM	Becton, Dickinson and Company Stock: Is Wall Street Bullish or Bearish? (Barchart)
Aug-17-25 11:34PM	Surgical Equipment & Consumables - Diversified Stocks Q2 Results: Benchmarking BD (NYSE:BDX) (StockStory)
Aug-14-25 04:15PM	BD to Present at Wells Fargo 2025 Healthcare Conference (PR Newswire)
10:00AM	ASEAN Infusion Pump Company Evaluation Report 2025 \| BD, Fresenius Kabi, and Terumo Lead with Innovations in Drug Delivery, Hospital Care, and Cardiovascular Solutions (GlobeNewswire)
01:35AM	5 Revealing Analyst Questions From BD's Q2 Earnings Call (StockStory)
Aug-12-25 12:30PM	[Latest] US Surgical Instrument Tracking Market Size/Share Worth USD 226.61 Million by 2034 at a 11.78% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) (GlobeNewswire)
09:45AM	Here's Why Becton Dickinson (BDX) is a Strong Growth Stock (Zacks)
03:22AM	BDX Q3 Deep Dive: Margin Expansion and Portfolio Moves Drive Positive Market Response (StockStory)
Aug-11-25 09:40AM	Why Becton Dickinson (BDX) is a Top Value Stock for the Long-Term (Zacks)
09:39AM	Loading…
Aug-08-25 09:39AM	Can Sustained Product Demand Drive CAH Stock Before Q4 Earnings? (Zacks)
09:27AM	Company News for Aug 8, 2025 (Zacks)
Aug-07-25 02:16PM	BD (NYSE:BDX) Reports Q2 In Line With Expectations, Stock Soars (StockStory) +8.86%
11:07AM	Analyst Report: Becton, Dickinson and Company (Morningstar Research)
11:02AM	BD Stock Gains in Pre-Market Following Q3 Earnings Beat, Margins Up (Zacks)
09:30AM	Here's What Key Metrics Tell Us About Becton Dickinson (BDX) Q3 Earnings (Zacks)
07:40AM	Becton Dickinson (BDX) Surpasses Q3 Earnings and Revenue Estimates (Zacks)
07:17AM	Becton Dickinson shares surge as Q3 earnings beat drives guidance hike (Investing.com)
06:41AM	Becton Dickinson: Fiscal Q3 Earnings Snapshot (Associated Press Finance)
06:30AM	BD Reports Third Quarter Fiscal 2025 Financial Results (PR Newswire)
Aug-06-25 10:36PM	Becton, Dickinson and Company Submits Application to the FDA for a New, At-Home HPV Test (Insider Monkey)
05:20PM	Staar Surgical (STAA) Reports Q2 Loss, Beats Revenue Estimates (Zacks)
08:09AM	Becton Dickinson (BDX) Fell Due to Decline in Organic Revenue Growth (Insider Monkey)
07:38AM	Should You Buy, Sell or Hold Hologic Stock Post Q3 Earnings? (Zacks)
Aug-05-25 11:09PM	What To Expect From BD's (BDX) Q2 Earnings (StockStory)
12:16PM	Loading…
12:16PM	Can Sustained Product Demand Drive BDX Stock Before Q3 Earnings? (Zacks)
08:02AM	Instylla Appoints MedTech Leader Sean Boyle as Chief Executive Officer (PR Newswire)
07:07AM	BD announces $35m investment to expand prefilled syringe manufacturing in US (Medical Device Network)
06:50AM	BD Businesses Become First in MedTech to Achieve HIRC's Diamond Badge Across All Supply Chain Resiliency Categories (PR Newswire)
Aug-04-25 09:15AM	Curious about Becton Dickinson (BDX) Q3 Performance? Explore Wall Street Estimates for Key Metrics (Zacks)
06:55AM	BD submits application to FDA for at-home HPV test (Medical Device Network)
06:50AM	BD to Invest $35 Million in Nebraska Facility to Expand Prefilled Flush Syringe Manufacturing to Support U.S. Health Care (PR Newswire)
Jul-31-25 04:15PM	BD Aims to Save Lives by Empowering Women with Choice and Access to Cervical Cancer Screening Self-Collected At Home (PR Newswire)
10:00AM	Earnings Preview: Becton Dickinson (BDX) Q3 Earnings Expected to Decline (Zacks)
Jul-30-25 06:50AM	BD Receives FDA 510(k) Clearance for Rapid Point-of-Care COVID-19 Test (PR Newswire)
Jul-25-25 07:30AM	Earnings Preview: What to Expect From Becton, Dickinson and Company's Report (Barchart)
Jul-24-25 09:06AM	Hologic's International Momentum Takes Shape: Will Execution Pay Off? (Zacks)
06:43AM	BD announces wearable injector trial for subcutaneous delivery of biologics (Medical Device Network)
Jul-23-25 10:00AM	Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever (Motley Fool)
09:20AM	Becton, Dickinson and Company (BDX) Fell in Q2 as Earnings Fell Short of Expectations (Insider Monkey)
06:50AM	BD Announces First Pharma-Sponsored Clinical Trial Using BD Libertas Wearable Injector Technology for Biologic Drugs (PR Newswire)
Jul-22-25 04:15PM	BD Board Declares Dividend (PR Newswire)
Jul-20-25 04:05AM	The Smartest Dividend Stock to Buy With $1,000 Right Now (Motley Fool)
Jul-18-25 11:07AM	Vascular Access Devices Company Evaluation Report 2025 \| Becton Dickinson, Teleflex, and ICU Medical Strengthen Global Leadership Through Strategic Acquisitions and Product Innovation (GlobeNewswire)
04:41AM	Jim Cramer Notes Becton Dickinson Stock Recently "Finished in the Black" (Insider Monkey)
Jul-15-25 02:47PM	Waters Corp. Deal for Becton Dickinson Unit a Long-Term Play With Some Risks (The Wall Street Journal)
10:25AM	Waters, BD Bioscience deal looks to be a good fit, says Stifel (TipRanks)
10:25AM	Waters deal adds variables to clean story, says Jefferies (TipRanks)
09:47AM	DoorDash, Southwest downgraded: Wall Street's top analyst calls (The Fly)
09:12AM	BD Partners With Waters to Build High-Volume Diagnostics Leader (Zacks)
08:29AM	Becton, Dickinson and Company (BDX) Traded Down on Weak Earnings (Insider Monkey)
06:56AM	BD Biosciences & Diagnostic Solutions and Waters to merge in $17.5bn deal (Medical Device Network)
Jul-14-25 11:35PM	Q1 Rundown: BD (NYSE:BDX) Vs Other Surgical Equipment & Consumables - Diversified Stocks (StockStory)
03:10PM	Analyst Report: Becton, Dickinson and Company (Morningstar Research)
01:15PM	Stock Market Today: Dow Flat As Nasdaq Ekes Out A Gain; This Rocket Stock Takes Off (Live Coverage) (Investor's Business Daily)
12:53PM	Stocks to Watch Monday: Tesla, Robinhood, Kenvue, Synopsys (The Wall Street Journal)
12:44PM	Top Stock Movers Now: Autodesk, Fortinet, Waters, and More (Investopedia)
11:14AM	Analytics Equipment Maker Waters Buys Becton Dickinson Unit in a $17.5B Deal (Investopedia)
11:06AM	Waters Stock Is Falling on Deal to Combine With Becton Dickinson Unit (Barrons.com)
11:05AM	Autodesk & PTC, Becton Dickson & Waters, crypto: Trending Tickers (Yahoo Finance Video)
10:31AM	Becton Dickinson Biosciences & Diagnostics Unit to Merge With Waters Corp. in $17.5 Billion Deal (The Wall Street Journal)
08:59AM	Here's Why Becton, Dickinson and Company (BDX) Traded Lower in Q2 (Insider Monkey)
07:48AM	Becton Dickinson gets its spinoff deal, but the stock is still falling (MarketWatch)
07:02AM	Becton Dickinson Unit to Combine With Waters Corp. in $17.5B Deal (The Wall Street Journal)
07:02AM	Becton Dickinson Unit to Combine With Waters Corp. in $17.5 Billion Deal (The Wall Street Journal)
06:15AM	Waters and BD's Biosciences & Diagnostic Solutions Business to Combine, Creating a Life Science and Diagnostics Leader Focused on Regulated, High-Volume Testing (PR Newswire)
Jul-07-25 04:15PM	BD Appoints Bilal Muhsin as Executive Vice President and President of Future Connected Care Segment (PR Newswire)
Jun-30-25 04:07PM	These Were the Best and Worst S&P 500 Stocks During the Second Quarter (Barrons.com)
Jun-26-25 02:55AM	BD's Q1 Earnings Call: Our Top 5 Analyst Questions (StockStory)
Jun-25-25 06:34PM	Becton, Dickinson and Company (BDX): A Bull Case Theory (Insider Monkey)
09:13AM	Analyst Report: Becton, Dickinson and Company (Morningstar Research)
09:13AM	How Hologic Leverages Its Financial Firepower to Drive Long-Term Value (Zacks)
Jun-23-25 04:56PM	Top Stock Reports for Amazon.com, Home Depot & Cisco Systems (Zacks)
Jun-09-25 08:42AM	Hologic Climbs 13% in a Month: How Should You Play the Stock? (Zacks)
06:00AM	As tech leads, which stocks have outperformed since April 8 rout? (Yahoo Finance Video)
Jun-08-25 08:00AM	Here's How You Can Earn $100 In Passive Income By Investing In Becton Dickinson Stock (Benzinga)
Jun-04-25 11:30AM	Henry Schein (HSIC) Up 6.5% Since Last Earnings Report: Can It Continue? (Zacks)
08:41AM	Hologic Navigates Breast Health Slump: Is the Growth Thesis Intact? (Zacks)
12:36AM	3 Healthcare Stocks Skating on Thin Ice (StockStory)
Jun-03-25 11:14AM	SOLV's Strong Q1 Signals Turnaround: Is the Stock Worth Betting Now? (Zacks)
May-30-25 10:14AM	BD Stock Might See Short-term Decline After Warning on Tamponade Tubes (Zacks)
May-29-25 05:10AM	BD to launch registry study of atherectomy system for PAD treatment (Medical Device Network)
May-28-25 06:50AM	BD to Initiate Real-World Patient Data Registry for the Rotarex Atherectomy System in Treatment of Peripheral Artery Disease (PR Newswire)
May-27-25 04:15PM	BD to Present at Goldman Sachs 46th Annual Global Healthcare Conference (PR Newswire)
May-21-25 06:38AM	Cancer Patients Face Elevated Risk of Carrying Antimicrobial Resistant 'Superbugs' (PR Newswire)
May-19-25 10:12AM	BD Stock May Rise Following the Launch of FACSDiscover A8 Platform (Zacks)
May-13-25 07:07AM	BD Launches Landmark Cell Analyzer Featuring Breakthrough Spectral and Real-Time Cell Imaging Technologies (PR Newswire)
May-12-25 05:02PM	First Eagle Investment's Strategic Moves: Spotlight on Becton Dickinson & Co (GuruFocus.com)
09:00AM	BD to Announce Financial Results for its Third Quarter of Fiscal 2025 (PR Newswire)
08:44AM	Tariffs Dim Hologic's 2025 Expectations: Time to Reassess the Stock? (Zacks)
May-09-25 12:39AM	3 Profitable Stocks with Questionable Fundamentals (StockStory)
May-07-25 01:28PM	Jim Cramer on Becton, Dickinson and Company (BDX): "A Shocking Miss for This Once-Reliable Med Tech Giant" (Insider Monkey)
12:16PM	S&P 500's five most overbought and oversold stocks (Seeking Alpha)
11:35AM	2024 Total Dividend Income And Portfolio Update (Seeking Alpha)
May-04-25 06:02PM	Becton, Dickinson, and Company (BDX): Among the Best Falling Stocks to Buy According to Analysts (Insider Monkey)

Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. It operates through the following segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment produces medical technologies and devices that are used to help improve healthcare delivery. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, instruments, and reagent systems to detect infectious diseases, healthcare-associated infections, and cancers. The BD Interventional segment offers vascular, urology, oncology, and surgical specialty products to hospitals, ambulatory surgery centers, individual healthcare professionals, extended care facilities, alternate site facilities, and patients via its Homecare business. The company was founded by Maxwell W. Becton and Fairleigh S. Dickinson in 1897 and is headquartered in Franklin Lakes, NJ.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Feld Michael	EVP & President, Life Sciences	Aug 22 '25	Sale	197.99	57	11,285	8,360	Aug 26 03:41 PM
MICHAEL FELD	Officer	Aug 22 '25	Proposed Sale	196.63	57	11,208		Aug 22 04:38 PM
HAYES GREGORY	Director	Aug 11 '25	Buy	191.57	5,250	1,005,742	6,046	Aug 11 04:15 PM
Fraser Claire	Director	Aug 08 '25	Sale	192.30	863	165,955	23,143	Aug 08 06:56 PM
Fraser Claire	Director	Aug 08 '25	Proposed Sale	192.21	863	165,880		Aug 08 02:32 PM
Garrison Michael David	EVP & President, Medical	Jul 18 '25	Option Exercise	147.68	6,360	939,245	11,247	Jul 22 05:29 PM
Garrison Michael David	EVP & President, Medical	Jul 18 '25	Sale	180.29	1,185	213,645	4,887	Jul 22 05:29 PM
MICHAEL GARRISON	Officer	Jul 18 '25	Proposed Sale	180.90	1,185	214,366		Jul 18 04:48 PM
Shan David	EVP and Chief ISC Officer	Jun 02 '25	Sale	171.19	1,166	199,608	4,575	Jun 02 06:44 PM
DAVID SHAN	Officer	Jun 02 '25	Proposed Sale	172.59	1,166	201,240		Jun 02 04:24 PM
Garrison Michael David	EVP & President, Medical	Apr 09 '25	Sale	197.28	479	94,497	4,887	Apr 10 01:56 PM
MICHAEL GARRISON	Officer	Apr 09 '25	Proposed Sale	200.83	479	96,198		Apr 09 04:16 PM
Byrd Richard	EVP & President Interventional	Mar 18 '25	Sale	230.00	459	105,570	6,952	Mar 19 01:55 PM
RICHARD BYRD	Officer	Mar 18 '25	Proposed Sale	227.83	459	104,574		Mar 18 04:33 PM
Byrd Richard	EVP & President Interventional	Mar 12 '25	Sale	224.91	1,940	436,325	7,411	Mar 13 01:03 PM
RICHARD BYRD	Officer	Mar 12 '25	Proposed Sale	224.92	1,940	436,345		Mar 12 04:22 PM
SCOTT BERTRAM L	Director	Feb 12 '25	Sale	227.99	700	159,593	36,033	Feb 12 04:44 PM
BERTRAM SCOTT	Director	Feb 12 '25	Proposed Sale	227.99	700	159,593		Feb 12 04:12 PM
Henderson Jeffrey William	Director	Feb 10 '25	Buy	233.62	1,500	350,430	8,015	Feb 10 05:03 PM
Shan David	EVP and Chief ISC Officer	Jan 21 '25	Sale	240.00	500	120,000	5,741	Jan 22 09:19 AM
Neal Shana Carol	EVP and Chief People Officer	Jan 21 '25	Sale	240.00	787	188,880	15,414	Jan 22 09:18 AM
SHANA NEAL	Officer	Jan 21 '25	Proposed Sale	237.38	787	186,818		Jan 21 04:21 PM
DAVID SHAN	Officer	Jan 21 '25	Proposed Sale	237.38	500	118,690		Jan 21 01:47 PM
Garrison Michael David	EVP & President, Medical	Jan 17 '25	Sale	236.51	597	141,196	5,544	Jan 21 08:21 AM
MICHAEL GARRISON	Officer	Jan 17 '25	Proposed Sale	236.30	597	141,071		Jan 17 04:20 PM
Neal Shana Carol	EVP and Chief People Officer	Nov 21 '24	Option Exercise	0.00	111	0	17,021	Jan 10 07:11 AM
Neal Shana Carol	EVP and Chief People Officer	Jan 07 '25	Sale	235.00	788	185,180	16,201	Jan 10 07:11 AM
SHANA NEAL	Officer	Jan 07 '25	Proposed Sale	230.70	788	181,792		Jan 07 04:19 PM
Garrison Michael David	EVP & President, Medical	Dec 19 '24	Sale	223.33	2,838	633,811	6,141	Dec 20 10:18 AM
MICHAEL GARRISON	Officer	Dec 19 '24	Proposed Sale	224.09	2,838	635,967		Dec 19 04:20 PM
Goette Roland	EVP and President, EMEA	Dec 06 '24	Option Exercise	157.30	13,334	2,097,403	28,828	Dec 10 08:23 PM
Goette Roland	EVP and President, EMEA	Dec 06 '24	Sale	221.01	4,483	990,788	24,345	Dec 10 08:23 PM
Goette Roland	EVP and President, EMEA	Dec 09 '24	Sale	219.03	638	139,741	14,217	Dec 10 08:23 PM
Neal Shana Carol	EVP and Chief People Officer	Dec 06 '24	Sale	220.49	1,000	220,490	16,989	Dec 10 08:17 PM
ROLAND GOETTE	Officer	Dec 09 '24	Proposed Sale	220.02	638	140,373		Dec 09 04:47 PM
Shan David	EVP and Chief ISC Officer	Dec 05 '24	Sale	220.25	1,500	330,375	6,285	Dec 06 04:55 PM
ROLAND GOETTE	Officer	Dec 06 '24	Proposed Sale	222.24	4,483	996,302		Dec 06 04:31 PM
SHANA NEAL	Officer	Dec 06 '24	Proposed Sale	222.24	1,000	222,240		Dec 06 04:31 PM
DAVID SHAN	Officer	Dec 05 '24	Proposed Sale	221.43	1,500	332,145		Dec 05 04:42 PM
BURZIK CATHERINE M	Director	Sep 16 '24	Proposed Sale	235.78	400	94,312		Sep 16 11:52 AM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Becton Dickinson & Co

Upgrade your FINVIZ experience